skip to content

Department of Pure Mathematics and Mathematical Statistics

Executive Director, Winton Centre for Risk and Evidence Communication

Publications

The effects of quality of evidence communication on perception of public health information about COVID-19: two randomised controlled trials
CR Schneider, ALJ Freeman, D Spiegelhalter, S van der Linden
– PLoS ONE
(2021)
16,
e0259048
Clinical Impact of the Predict Prostate Risk Communication Tool in Men Newly Diagnosed with Nonmetastatic Prostate Cancer: A Multicentre Randomised Controlled Trial.
D Thurtle, V Jenkins, A Freeman, M Pearson, G Recchia, P Tamer, K Leonard, P Pharoah, J Aning, S Madaan, C Goh, S Hilman, S McCracken, PC Ilie, H Lazarowicz, V Gnanapragasam
– European urology
(2021)
80,
661
Expert elicitation on the relative importance of possible SARS-CoV-2 transmission routes and the effectiveness of mitigations
ALJ Freeman, S Parker, C Noakes, S Fitzgerald, A Smyth, R Macbeth, D Spiegelhalter, H Rutter
– BMJ Open
(2021)
11,
e050869
How People Understand Risk Matrices, and How Matrix Design Can Improve their Use: Findings from Randomized Controlled Studies
H Sutherland, G Recchia, S Dryhurst, ALJ Freeman
– Risk analysis : an official publication of the Society for Risk Analysis
(2021)
Correlates of intended COVID-19 vaccine acceptance across time and countries: results from a series of cross-sectional surveys.
JR Kerr, CR Schneider, G Recchia, S Dryhurst, U Sahlin, C Dufouil, P Arwidson, AL Freeman, S van der Linden
– BMJ Open
(2021)
11,
e048025
Redevelopment of the Predict: Breast Cancer website and recommendations for developing interfaces to support decisionā€making
GD Farmer, M Pearson, WJ Skylark, ALJ Freeman, DJ Spiegelhalter
– Cancer Med
(2021)
10,
5141
How Accurate Are Accuracy-Nudge Interventions? A Preregistered Direct Replication of Pennycook et al. (2020)
J Roozenbeek, ALJ Freeman, S van der Linden
– Psychol Sci
(2021)
32,
1169
Clinical impact of the predict prostate risk communication tool in men newly diagnosed with non-metastatic prostate cancer: A multi-centre randomised controlled trial
D Thurtle, V Jenkins, A Freeman, M Pearson, G Recchia, P Tamer, K Leonard, PD Pharoah, J Aning, S Madaan, C Goh, S Hilman, S Mccracken, C Ilie, H Lazarowicz, V Gnanapragasam
– EUROPEAN UROLOGY
(2021)
79,
S1446
How do the UK public interpret COVID-19 test results? Comparing the impact of official information about results and reliability used in the UK, USA and New Zealand: a randomised controlled trial.
G Recchia, CR Schneider, AL Freeman
– BMJ open
(2021)
11,
e047731
How well did experts and laypeople forecast the size of the COVID-19 pandemic?
G Recchia, ALJ Freeman, D Spiegelhalter
– PloS one
(2021)
16,
e0250935
  • 1 of 5
  • >

Room

E0.07

Telephone

01223 764256